These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 38184234)
1. An inoculation site-retained mRNA vaccine induces robust immune responses against SARS-CoV-2 variants. Huang L; Zhao F; He M; Fang Y; Ma X; Lu S; Li E; Xiao H; Zhu H; Wang X; Tang S; Yu B; Wang J; Zhao D; Wang C; Li H; Gao Y; Peng X; Shen H J Control Release; 2024 Feb; 366():479-493. PubMed ID: 38184234 [TBL] [Abstract][Full Text] [Related]
2. Humoral and Cellular Immune Responses to Vector, Mix-and-Match, or mRNA Vaccines against SARS-CoV-2 and the Relationship between the Two Immune Responses. Nam M; Yun SG; Kim SW; Kim CG; Cha JH; Lee C; Kang S; Park SG; Kim SB; Lee KB; Chung YS; Nam MH; Lee CK; Cho Y Microbiol Spectr; 2022 Aug; 10(4):e0249521. PubMed ID: 35946811 [TBL] [Abstract][Full Text] [Related]
3. A core-shell structured COVID-19 mRNA vaccine with favorable biodistribution pattern and promising immunity. Yang R; Deng Y; Huang B; Huang L; Lin A; Li Y; Wang W; Liu J; Lu S; Zhan Z; Wang Y; A R; Wang W; Niu P; Zhao L; Li S; Ma X; Zhang L; Zhang Y; Yao W; Liang X; Zhao J; Liu Z; Peng X; Li H; Tan W Signal Transduct Target Ther; 2021 May; 6(1):213. PubMed ID: 34059617 [TBL] [Abstract][Full Text] [Related]
4. A dual-antigen self-amplifying RNA SARS-CoV-2 vaccine induces potent humoral and cellular immune responses and protects against SARS-CoV-2 variants through T cell-mediated immunity. McCafferty S; Haque AKMA; Vandierendonck A; Weidensee B; Plovyt M; Stuchlíková M; François N; Valembois S; Heyndrickx L; Michiels J; Ariën KK; Vandekerckhove L; Abdelnabi R; Foo CS; Neyts J; Sahu I; Sanders NN Mol Ther; 2022 Sep; 30(9):2968-2983. PubMed ID: 35450821 [TBL] [Abstract][Full Text] [Related]
5. Trivalent mRNA Vaccine against SARS-CoV-2 and Variants with Effective Immunization. Wang J; Zhang Y; Liu C; Zha W; Dong S; Wang Y; Jiang Y; Xing H; Li X Mol Pharm; 2023 Oct; 20(10):4971-4983. PubMed ID: 37699256 [TBL] [Abstract][Full Text] [Related]
6. Broad-spectrum Delta-BA.2 tandem-fused heterodimer mRNA vaccine delivered by lipopolyplex. Du P; Huang L; Fang Y; Zhao F; Li Q; Ma X; Li R; Chen Q; Shen H; Wang Q; Li H; Gao GF PLoS Pathog; 2024 Apr; 20(4):e1012116. PubMed ID: 38557908 [TBL] [Abstract][Full Text] [Related]
7. A single immunization with core-shell structured lipopolyplex mRNA vaccine against rabies induces potent humoral immunity in mice and dogs. Wan J; Yang J; Wang Z; Shen R; Zhang C; Wu Y; Zhou M; Chen H; Fu ZF; Sun H; Yi Y; Shen H; Li H; Zhao L Emerg Microbes Infect; 2023 Dec; 12(2):2270081. PubMed ID: 37819147 [TBL] [Abstract][Full Text] [Related]
8. Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trial. Chen GL; Li XF; Dai XH; Li N; Cheng ML; Huang Z; Shen J; Ge YH; Shen ZW; Deng YQ; Yang SY; Zhao H; Zhang NN; Zhang YF; Wei L; Wu KQ; Zhu MF; Peng CG; Jiang Q; Cao SC; Li YH; Zhao DH; Wu XH; Ni L; Shen HH; Dong C; Ying B; Sheng GP; Qin CF; Gao HN; Li LJ Lancet Microbe; 2022 Mar; 3(3):e193-e202. PubMed ID: 35098177 [TBL] [Abstract][Full Text] [Related]
9. Hybrid Immunity Shifts the Fc-Effector Quality of SARS-CoV-2 mRNA Vaccine-Induced Immunity. Bowman KA; Stein D; Shin S; Ferbas KG; Tobin NH; Mann C; Fischinger S; Ollmann Saphire E; Lauffenburger D; Rimoin AW; Aldrovandi G; Alter G mBio; 2022 Oct; 13(5):e0164722. PubMed ID: 36000735 [TBL] [Abstract][Full Text] [Related]
10. Comparison of Immune Responses Elicited by SARS-CoV-2 mRNA and Recombinant Protein Vaccine Candidates. Wu Y; Zhang H; Meng L; Li F; Yu C Front Immunol; 2022; 13():906457. PubMed ID: 35663946 [TBL] [Abstract][Full Text] [Related]
11. Circular RNA vaccines against SARS-CoV-2 and emerging variants. Qu L; Yi Z; Shen Y; Lin L; Chen F; Xu Y; Wu Z; Tang H; Zhang X; Tian F; Wang C; Xiao X; Dong X; Guo L; Lu S; Yang C; Tang C; Yang Y; Yu W; Wang J; Zhou Y; Huang Q; Yisimayi A; Liu S; Huang W; Cao Y; Wang Y; Zhou Z; Peng X; Wang J; Xie XS; Wei W Cell; 2022 May; 185(10):1728-1744.e16. PubMed ID: 35460644 [TBL] [Abstract][Full Text] [Related]
12. Vaccine-Induced Antibody Responses against SARS-CoV-2 Variants-Of-Concern Six Months after the BNT162b2 COVID-19 mRNA Vaccination. Jalkanen P; Kolehmainen P; Haveri A; Huttunen M; Laine L; Österlund P; Tähtinen PA; Ivaska L; Maljanen S; Reinholm A; Belik M; Smura T; Häkkinen HK; Ortamo E; Kantele A; Julkunen I; Lempainen J; Kakkola L Microbiol Spectr; 2022 Apr; 10(2):e0225221. PubMed ID: 35262410 [TBL] [Abstract][Full Text] [Related]
14. Boosting with Multiple Doses of mRNA Vaccine after Priming with Two Doses of Protein Subunit Vaccine MVC-COV1901 Elicited Robust Humoral and Cellular Immune Responses against Emerging SARS-CoV-2 Variants. Chiu CH; Chang YH; Tao CW; Chang FY; Chiu KC; Chang TW; Yen LC Microbiol Spectr; 2022 Oct; 10(5):e0060922. PubMed ID: 36005765 [TBL] [Abstract][Full Text] [Related]
15. A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice. Laczkó D; Hogan MJ; Toulmin SA; Hicks P; Lederer K; Gaudette BT; Castaño D; Amanat F; Muramatsu H; Oguin TH; Ojha A; Zhang L; Mu Z; Parks R; Manzoni TB; Roper B; Strohmeier S; Tombácz I; Arwood L; Nachbagauer R; Karikó K; Greenhouse J; Pessaint L; Porto M; Putman-Taylor T; Strasbaugh A; Campbell TA; Lin PJC; Tam YK; Sempowski GD; Farzan M; Choe H; Saunders KO; Haynes BF; Andersen H; Eisenlohr LC; Weissman D; Krammer F; Bates P; Allman D; Locci M; Pardi N Immunity; 2020 Oct; 53(4):724-732.e7. PubMed ID: 32783919 [TBL] [Abstract][Full Text] [Related]
16. Preclinical evaluation of RQ3013, a broad-spectrum mRNA vaccine against SARS-CoV-2 variants. Tan S; Zhao J; Hu X; Li Y; Wu Z; Lu G; Yu Z; Du B; Liu Y; Li L; Chen Y; Li Y; Yao Y; Zhang X; Rao J; Gao G; Peng Y; Liu H; Yuan Z; Liu J; Wang Q; Hu H; Gao X; Zhou H; Yu H; Xu Y; Yu W; Feng L; Wang M; Shan C; Lu J; Lin J Sci Bull (Beijing); 2023 Dec; 68(24):3192-3206. PubMed ID: 37993332 [TBL] [Abstract][Full Text] [Related]